These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33717720)

  • 1. Hyponatremia and Its Correlation With Hepatic Encephalopathy and Severity of Liver Disease.
    Younas A; Riaz J; Chughtai T; Maqsood H; Saim M; Qazi S; Younus S; Ghaffar U; Khaliq M
    Cureus; 2021 Feb; 13(2):e13175. PubMed ID: 33717720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease.
    Qureshi MO; Khokhar N; Saleem A; Niazi TK
    J Coll Physicians Surg Pak; 2014 Feb; 24(2):135-7. PubMed ID: 24491011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of hyponatraemia and its influence on liver cirrhosis-related complications.
    Shaikh S; Mal G; Khalid S; Baloch GH; Akbar Y
    J Pak Med Assoc; 2010 Feb; 60(2):116-20. PubMed ID: 20209698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the serum sodium level and the severity of complications in liver cirrhosis.
    Kim JH; Lee JS; Lee SH; Bae WK; Kim NH; Kim KA; Moon YS
    Korean J Intern Med; 2009 Jun; 24(2):106-12. PubMed ID: 19543488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications and Mortality in Hospitalised Patients With Decompensated Cirrhosis of Liver in a Tertiary Care Centre in Nepal.
    Bhattarai S
    Cureus; 2020 Aug; 12(8):e9996. PubMed ID: 32983695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hyponatremia on frequency of complications in patients with decompensated liver cirrhosis.
    Barakat AA; Metwaly AA; Nasr FM; El-Ghannam M; El-Talkawy MD; Taleb HA
    Electron Physician; 2015 Oct; 7(6):1349-58. PubMed ID: 26516441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure.
    Chiriac S; Stanciu C; Cojocariu C; Singeap AM; Sfarti C; Cuciureanu T; Girleanu I; Igna RA; Trifan A
    World J Clin Cases; 2021 Jan; 9(3):552-564. PubMed ID: 33553393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ammonia levels and the severity of hepatic encephalopathy.
    Qureshi MO; Khokhar N; Shafqat F
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hyponatremia in chronic liver disease patients and it's correlation with the severity of the disease.
    G S; C P; C A; Ms S; S M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyponatremia in cirrhosis: Risk factors and prognostic value.
    Ennaifer R; Cheikh M; Romdhane H; El Elj R; Ben Nejma H; Bougassas W; Bel Hadj N
    Tunis Med; 2016 May; 94(5):401-405. PubMed ID: 27801493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of multi-slice spiral computed tomography portography in assessing severity of liver cirrhosis and predicting episode risks of hepatic encephalopathy].
    Liu W; Wang J; Feng Y; Dai G; Ning T
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):509-13. PubMed ID: 25203802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study.
    Wunsch E; Naprawa G; Koziarska D; Milkiewicz M; Nowacki P; Milkiewicz P
    Ann Hepatol; 2013; 12(3):448-55. PubMed ID: 23619262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
    Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
    Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
    Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
    Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of hyponatremia and hepatic encephalopathy on inpatient mortality.
    Chauhan M; Zhang T; Thuluvath PJ
    Ann Hepatol; 2023; 28(3):101084. PubMed ID: 36878465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia: A Risk Factor for Early Overt Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.
    Merola J; Chaudhary N; Qian M; Jow A; Barboza K; Charles H; Teperman L; Sigal S
    J Clin Med; 2014 Apr; 3(2):359-72. PubMed ID: 26237379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study].
    Fan YN; Ji TT; Liang RY; Yu YY; Xu JH
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.